Ann: Receipt of the R & D Tax Incentive Refund, page-4

LAST UPDATED: 1 DECEMBER 2023 AT 11:00AM ESTSimon Morriss Net WorthMr. Simon Morriss biographySimon Morriss is the Chief Exec. Officer at Genetic Technologies.What is the salary of Mr Morriss?As the Chief Exec. Officer of Genetic Technologies, the total compensation of Mr Morriss at Genetic Technologies is $270,520. There are 1 executives at Genetic Technologies getting paid more, with Mark Ostrowski having the highest compensation of $296,280.
Genetic Technologies executives and stock ownersGenetic Technologies executives and other stock owners filed with the SEC include:Mark Ostrowski, President of Phenogen Sciences IncSimon Morriss, Chief Exec. OfficerMichael Tonroe ACA, B.Sc., Bsc(Hons), F.C.A., M.A.I.C.D., MAICD, CFO & Company Sec.M. Luisa Ashdown, Director of Global Licensing and Intellectual PropertyDr. Richard Allman, Chief Scientific OfficerRichard Allman, Scientific DirectorStanley Sack, Chief Operating OfficerLindsay Wakefield, Non-Executive Independent DirectorNick Burrows, Non-Executive DirectorJustyn Stedwell, Company SecretaryDiana Newport, Quality and Business Operations DirectorSusan Gross, Senior Medical DirectorStan Sack, Chief Operating OfficerPhillip Hains, Chief Financial OfficerJerzy Muchnicki, Interim Chief Executive Officer, DirectorPeter Rubenstein, Chairman of the BoardCarl S. Stubbings BSc, Chief Commercial OfficerPaul Keith Mathieson Viney B. Bus, FCI, FCPA, FGIA, Consultant
Investing in these securities involves a high degree of risk. Please carefully consider the risks discussed in this prospectus under “Risk Factors” in this prospectus, in any accompanying prospectus supplement and in the documents incorporated by reference in this prospectus for a discussion of the factors you should carefully consider before deciding to purchase these securities.